Skip to main content
. 2022 Aug 26;13:911801. doi: 10.3389/fgene.2022.911801

TABLE 1.

Clinical and pathological features according to the EMT clusters.

Clinical and pathological factors EMT C1 EMT C2 p-value
Progression status Progression 127 229 <0.001*
Progression free 318 340
Mean (SD) 67.6 (8.5) 65.2 (9.9)
Sex Female 115 291 <0.001
Male 330 278
Race Asian 6 10 0.784
Black 31 51
White 305 431
American Indian 1
pT stage T1 41 75 0.005
T1a 20 51
T1b 34 61
T2 155 184
T2a 82 87
T2b 33 28
T3 61 57
T4 19 23
TX 3
pN stage N0 292 357 0.001
N1 113 113
N2 31 83
N3 4 3
NX 5 12
pM stage M0 356 399 0.003
M1 5 18
M1a 1 2
M1b 1 5
MX 78 141
pTNM stage I 3 5 <0.001
IA 75 145
IB 147 143
II 3 1
IIA 58 57
IIB 82 82
III 2 1
IIIA 51 85
IIIB 15 14
IV 7 26
Metastasis status Metastasis 34 62 0.546
Metastasis: primary 2 1
Metastasis: recurrence 2 9
Primary 9 14
Recurrence 25 52
Smoking history Non-smoking 14 78 <0.001
Smoking 421 475
Radioation history Non-radiation 132 148 0.928
Radiation 14 14

*p value <0.05 are marked in bold.